Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in t ...

Dynavax Technologies (NASDAQ:DVAX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. A number ...

Envista Holdings Corporation ("Envista") proudly announced that in 2024, the Envista Smile Project (Smile Project) contributed $1.8 million to further its mission of enhancing oral health ...

MURFREESBORO, TN / ACCESS Newswire / February 25, 2025 / National Health Investors, Inc. announced today that it will pay its first quarter dividend of $0.90 per common share on May 2, 2025 to ...

The pharma group has just announced that it will build four new manufacturing facilities in the US – at a cost of around $27 ...

The finding is significant because people can use CGM data to make dietary and lifestyle changes, which may be unnecessary, ...